Serum levels of vascular endothelial growth factor and cavity formation in active pulmonary tuberculosis

被引:23
作者
Abe, Y
Nakamura, M
Oshika, Y
Hatanaka, H
Tokunaga, T
Ohkubo, Y
Hashizume, T
Suzuki, K
Fujino, T
机构
[1] Natl Sanatorium Kanagawa Hosp, Dept Resp Dis, Hadano, Kanagawa 2578585, Japan
[2] Tokai Univ, Sch Med, Dept Pathol, Isehara, Kanagawa 25911, Japan
关键词
vascular endothelial growth factor; tuberculosis; lung; cavity; high-resolution computed tomography;
D O I
10.1159/000050557
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background. In active pulmonary tuberculosis, certain cytokines have been postulated to be related to cavity formation, although the detailed mechanism of cavity formation is not yet known. Objective: We examined the relationship between cavity formation in pulmonary tuberculosis and vascular endothelial growth factor (VEGF), which functions as an angiogenesis factor. Methods: Forty-eight patients with active pulmonary tuberculosis were divided into two groups according to cavity formation as evaluated by chest high-resolution computed tomography. We evaluated serum VEGF levels by enzyme immunoassay. Results: Group A (with cavities) was comprised of 22 patients and group B (without cavities) was comprised of 26 patients. The serum levels of VEGF were significantly higher in group B (58.733 +/- 21.612 pg/ml) than those in normal individuals (8.739 +/- 3.656 pg/ml) and in group A (13.053 +/- 8.670 pg/ml) (Mann-Whitney U test, p = 0.0149 and p = 0.0481, respectively). Serum levels of interleukin-8 and tumor necrosis factor-alpha were not significantly different between the two groups. Conclusion: These findings suggested that increased serum VEGF levels subdue cavity formation in active pulmonary tuberculosis. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:496 / 500
页数:5
相关论文
共 27 条
[1]   VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS [J].
AIELLO, LP ;
AVERY, RL ;
ARRIGG, PG ;
KEYT, BA ;
JAMPEL, HD ;
SHAH, ST ;
PASQUALE, LR ;
THIEME, H ;
IWAMOTO, MA ;
PARK, JE ;
NGUYEN, HV ;
AIELLO, LM ;
FERRARA, N ;
KING, GL .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) :1480-1487
[2]  
[Anonymous], TUBERCLE BACILLUS PU
[3]   ROLE OF GAMMA-INTERFERON AND TUMOR-NECROSIS-FACTOR-ALPHA DURING T-CELL-INDEPENDENT AND T-CELL-DEPENDENT PHASES OF MYCOBACTERIUM-AVIUM INFECTION [J].
APPELBERG, R ;
CASTRO, AG ;
PEDROSA, J ;
SILVA, RA ;
ORME, IM ;
MINOPRIO, P .
INFECTION AND IMMUNITY, 1994, 62 (09) :3962-3971
[4]  
BREIER G, 1992, DEVELOPMENT, V114, P521
[5]   EXPRESSION OF VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) AND ITS RECEPTORS IN BREAST-CANCER [J].
BROWN, LF ;
BERSE, B ;
JACKMAN, RW ;
TOGNAZZI, K ;
GUIDI, AJ ;
DVORAK, HF ;
SENGER, DR ;
CONNOLLY, JL ;
SCHNITT, SJ .
HUMAN PATHOLOGY, 1995, 26 (01) :86-91
[6]   Cytokine levels correlate with a radiologic score in active pulmonary tuberculosis [J].
Casarini, M ;
Ameglio, F ;
Alemanno, L ;
Zangrilli, P ;
Mattia, P ;
Paone, G ;
Bisetti, A ;
Giosuè, S .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (01) :143-148
[7]   Effect of Mycobacterium tuberculosis and its components on macrophages and the release of matrix metalloproteinases [J].
Chang, JC ;
Wysocki, A ;
TchouWong, KM ;
Moskowitz, N ;
Zhang, YH ;
Rom, WN .
THORAX, 1996, 51 (03) :306-311
[8]   Local immune responses correlate with presentation and outcome in tuberculosis [J].
Condos, R ;
Rom, WN ;
Liu, YM ;
Schluger, NW .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (03) :729-735
[9]  
Dannenberg A.M., 1988, PULMONARY DISEASES D, V3, P1821
[10]  
DENIS M, 1991, CLIN EXP IMMUNOL, V84, P200, DOI 10.1111/j.1365-2249.1991.tb08149.x